RxDoctor Payments Data

Brittany Klinger, APRN

Family · Wintersville, OHNPI 1992259865

Payments from drug & device makers

$1,820in general payments, 2019–2025

Across 112 payments — averaging $16.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$587
  • Novo Nordisk$291
  • GSK$210
  • Lilly USA, LLC$191
  • Abbott$136
  • Amarin Pharma, Inc.$124
  • plus $282 from 9 others

What the payments were for

  • Food & beverage$1,820100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,820 in reported general payments places this provider in the 80th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$28,104
Medicare patients
127
Services billed
331

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide56$75,002
JardianceEmpagliflozin34$42,250
Trelegy ElliptaFluticasone/Umeclidin/Vilanter50$35,198
JanuviaSitagliptin Phosphate22$28,609
Spiriva RespimatTiotropium Bromide15$16,352
EliquisApixaban13$12,177
XareltoRivaroxaban14$9,747
KerendiaFinerenone11$7,690
Incruse ElliptaUmeclidinium Bromide19$7,063
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,603
Tresiba Flextouch U-100Insulin Degludec24$4,347
VascepaIcosapent Ethyl14$4,059
Fluticasone Propionate HfaFluticasone Propionate14$3,490
Albuterol Sulfate HfaAlbuterol Sulfate94$2,504
Levothyroxine Sodium294$2,409

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$291$75,00256 claims
Boehringer IngelheimJardiance, Spiriva Respimat$21$58,60249 claims
GSKTrelegy Ellipta, Incruse Ellipta, Anoro Ellipta$210$47,86481 claims
PfizerEliquis$15$12,17713 claims
Johnson & JohnsonXarelto$15$9,74714 claims
BayerKerendia$16$7,69011 claims
AbbVieSynthroid$71$1,51116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,812 family providers in Ohio.

Other family in Wintersville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →